Tinzaparin

BreastfeedingGeriatricPediatric
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Aliskiren, Angiotensin II recepton antagonists, Aspirin, Butabarbital, Clopidogrel, Collagenase, Dasatinib, Dextran, Diclofenac, Dipyridamole, Drotrecogin Alfa, Glyceryl trinitrate, Ibritumomab, Iloprost, Ketorolac, NSAIDs, Oral anticoagulants, Pentosan, Pentoxifylline, Platelet inhibitors, Prostacyclin analogues, Salicylates, Sulfinpyrazone, Throbolytics, Ticlopidine, Tositumomab & Iodine131

PREGNANCY CATEGORY: B

BLACK BOX WARNING
SPINAL / EPIDURAL HEMATOMAS

See full prescribing information for complete boxed warning.

Our database has 38 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
HAIR.
NAILS.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OCULAR.
RESPIRATORY.
OTHER.


Page last updated 08/01/2022

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top